Making wider use of the world's most widely used vaccine: Bacille Calmette–Guérin revaccination reconsidered

Approximately 100 million newborn children receive Bacille Calmette–Guérin (BCG) annually, because vaccination is consistently protective against childhood tuberculous meningitis and miliary TB. By contrast, BCG efficacy against pulmonary TB in children and adults is highly variable, ranging from 0%...

Descripción completa

Detalles Bibliográficos
Autor principal: Dye, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society 2013
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757998/
https://www.ncbi.nlm.nih.gov/pubmed/23904584
http://dx.doi.org/10.1098/rsif.2013.0365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757998/
https://www.ncbi.nlm.nih.gov/pubmed/23904584
http://dx.doi.org/10.1098/rsif.2013.0365

Ejemplares similares